Clinical Trial Update: Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update for universal CAR-T cells REVO-UWD-03 in advanced hepatocellular carcinoma and non-small cell lung cancer, currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• REVO-UWD-03

Snippet

Sponsor: Wondercel Biotech (ShenZhen) | Conditions: HCC - Hepatocellular Carcinoma, NSCLC (Advanced Non-small Cell Lung Cancer) | EARLY_Phase 1 | Status: RECRUITING